 | • レポートコード：MRC2-11QY11191 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器・消耗品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は乳癌リキッドバイオプシーのグローバル市場について調査・分析したレポートです。種類別（循環腫瘍細胞（CTC）、無細胞DNA（CfDNA）、細胞外小胞（EV）、その他循環バイオマーカー）市場規模、用途別（病院、診断センター、研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別乳癌リキッドバイオプシーの競争状況、市場シェア ・世界の乳癌リキッドバイオプシー市場：種類別市場規模 2015年-2020年（循環腫瘍細胞（CTC）、無細胞DNA（CfDNA）、細胞外小胞（EV）、その他循環バイオマーカー） ・世界の乳癌リキッドバイオプシー市場：種類別市場規模予測 2021年-2026年（循環腫瘍細胞（CTC）、無細胞DNA（CfDNA）、細胞外小胞（EV）、その他循環バイオマーカー） ・世界の乳癌リキッドバイオプシー市場：用途別市場規模 2015年-2020年（病院、診断センター、研究所） ・世界の乳癌リキッドバイオプシー市場：用途別市場規模予測 2021年-2026年（病院、診断センター、研究所） ・北米の乳癌リキッドバイオプシー市場分析：米国、カナダ ・ヨーロッパの乳癌リキッドバイオプシー市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの乳癌リキッドバイオプシー市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の乳癌リキッドバイオプシー市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの乳癌リキッドバイオプシー市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：QIAGEN、Roche Diagnostics、Bio-Rad Laboratories、Myriad Genetics、Menarini Silicon Biosystems、Genomic Health、Thermo Fisher Scientific、Illumina、Biocept、Trovagene、Guardant Health、RainDance Technologies、MDx Health ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Breast Cancer Liquid Biopsy can be usually used in breast biopsy, based on circulating biomarkers, the market is categorized into circulating tumor cells (CTCs), cell-free DNA (cfDNA), extracellular vesicles (EVs), and other circulating biomarkers.
Market Analysis and Insights: Global Breast Cancer Liquid Biopsy Market
The global Breast Cancer Liquid Biopsy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Breast Cancer Liquid Biopsy Scope and Market Size
Breast Cancer Liquid Biopsy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Breast Cancer Liquid Biopsy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
QIAGEN
Roche Diagnostics
Bio-Rad Laboratories
Myriad Genetics
Menarini Silicon Biosystems
Genomic Health
Thermo Fisher Scientific
Illumina
Biocept
Trovagene
Guardant Health
RainDance Technologies
MDx Health
Market segment by Type, the product can be split into
Circulating Tumor Cells (CTCs)
Cell-Free DNA (CfDNA)
Extracellular Vesicles (EVs)
Other Circulating Biomarkers
Market segment by Application, split into
Hospitals
Diagnostic Centers
Laboratories
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Breast Cancer Liquid Biopsy Revenue
1.4 Market by Type
1.4.1 Global Breast Cancer Liquid Biopsy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Circulating Tumor Cells (CTCs)
1.4.3 Cell-Free DNA (CfDNA)
1.4.4 Extracellular Vesicles (EVs)
1.4.5 Other Circulating Biomarkers
1.5 Market by Application
1.5.1 Global Breast Cancer Liquid Biopsy Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Diagnostic Centers
1.5.4 Laboratories
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Breast Cancer Liquid Biopsy Market Perspective (2015-2026)
2.2 Global Breast Cancer Liquid Biopsy Growth Trends by Regions
2.2.1 Breast Cancer Liquid Biopsy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Breast Cancer Liquid Biopsy Historic Market Share by Regions (2015-2020)
2.2.3 Breast Cancer Liquid Biopsy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Breast Cancer Liquid Biopsy Market Growth Strategy
2.3.6 Primary Interviews with Key Breast Cancer Liquid Biopsy Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Breast Cancer Liquid Biopsy Players by Market Size
3.1.1 Global Top Breast Cancer Liquid Biopsy Players by Revenue (2015-2020)
3.1.2 Global Breast Cancer Liquid Biopsy Revenue Market Share by Players (2015-2020)
3.1.3 Global Breast Cancer Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Breast Cancer Liquid Biopsy Market Concentration Ratio
3.2.1 Global Breast Cancer Liquid Biopsy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Breast Cancer Liquid Biopsy Revenue in 2019
3.3 Breast Cancer Liquid Biopsy Key Players Head office and Area Served
3.4 Key Players Breast Cancer Liquid Biopsy Product Solution and Service
3.5 Date of Enter into Breast Cancer Liquid Biopsy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Breast Cancer Liquid Biopsy Historic Market Size by Type (2015-2020)
4.2 Global Breast Cancer Liquid Biopsy Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Breast Cancer Liquid Biopsy Market Size by Application (2015-2020)
5.2 Global Breast Cancer Liquid Biopsy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Breast Cancer Liquid Biopsy Market Size (2015-2020)
6.2 Breast Cancer Liquid Biopsy Key Players in North America (2019-2020)
6.3 North America Breast Cancer Liquid Biopsy Market Size by Type (2015-2020)
6.4 North America Breast Cancer Liquid Biopsy Market Size by Application (2015-2020)
7 Europe
7.1 Europe Breast Cancer Liquid Biopsy Market Size (2015-2020)
7.2 Breast Cancer Liquid Biopsy Key Players in Europe (2019-2020)
7.3 Europe Breast Cancer Liquid Biopsy Market Size by Type (2015-2020)
7.4 Europe Breast Cancer Liquid Biopsy Market Size by Application (2015-2020)
8 China
8.1 China Breast Cancer Liquid Biopsy Market Size (2015-2020)
8.2 Breast Cancer Liquid Biopsy Key Players in China (2019-2020)
8.3 China Breast Cancer Liquid Biopsy Market Size by Type (2015-2020)
8.4 China Breast Cancer Liquid Biopsy Market Size by Application (2015-2020)
9 Japan
9.1 Japan Breast Cancer Liquid Biopsy Market Size (2015-2020)
9.2 Breast Cancer Liquid Biopsy Key Players in Japan (2019-2020)
9.3 Japan Breast Cancer Liquid Biopsy Market Size by Type (2015-2020)
9.4 Japan Breast Cancer Liquid Biopsy Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Breast Cancer Liquid Biopsy Market Size (2015-2020)
10.2 Breast Cancer Liquid Biopsy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Breast Cancer Liquid Biopsy Market Size by Type (2015-2020)
10.4 Southeast Asia Breast Cancer Liquid Biopsy Market Size by Application (2015-2020)
11 India
11.1 India Breast Cancer Liquid Biopsy Market Size (2015-2020)
11.2 Breast Cancer Liquid Biopsy Key Players in India (2019-2020)
11.3 India Breast Cancer Liquid Biopsy Market Size by Type (2015-2020)
11.4 India Breast Cancer Liquid Biopsy Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Breast Cancer Liquid Biopsy Market Size (2015-2020)
12.2 Breast Cancer Liquid Biopsy Key Players in Central & South America (2019-2020)
12.3 Central & South America Breast Cancer Liquid Biopsy Market Size by Type (2015-2020)
12.4 Central & South America Breast Cancer Liquid Biopsy Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 QIAGEN
13.1.1 QIAGEN Company Details
13.1.2 QIAGEN Business Overview
13.1.3 QIAGEN Breast Cancer Liquid Biopsy Introduction
13.1.4 QIAGEN Revenue in Breast Cancer Liquid Biopsy Business (2015-2020))
13.1.5 QIAGEN Recent Development
13.2 Roche Diagnostics
13.2.1 Roche Diagnostics Company Details
13.2.2 Roche Diagnostics Business Overview
13.2.3 Roche Diagnostics Breast Cancer Liquid Biopsy Introduction
13.2.4 Roche Diagnostics Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
13.2.5 Roche Diagnostics Recent Development
13.3 Bio-Rad Laboratories
13.3.1 Bio-Rad Laboratories Company Details
13.3.2 Bio-Rad Laboratories Business Overview
13.3.3 Bio-Rad Laboratories Breast Cancer Liquid Biopsy Introduction
13.3.4 Bio-Rad Laboratories Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
13.3.5 Bio-Rad Laboratories Recent Development
13.4 Myriad Genetics
13.4.1 Myriad Genetics Company Details
13.4.2 Myriad Genetics Business Overview
13.4.3 Myriad Genetics Breast Cancer Liquid Biopsy Introduction
13.4.4 Myriad Genetics Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
13.4.5 Myriad Genetics Recent Development
13.5 Menarini Silicon Biosystems
13.5.1 Menarini Silicon Biosystems Company Details
13.5.2 Menarini Silicon Biosystems Business Overview
13.5.3 Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Introduction
13.5.4 Menarini Silicon Biosystems Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
13.5.5 Menarini Silicon Biosystems Recent Development
13.6 Genomic Health
13.6.1 Genomic Health Company Details
13.6.2 Genomic Health Business Overview
13.6.3 Genomic Health Breast Cancer Liquid Biopsy Introduction
13.6.4 Genomic Health Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
13.6.5 Genomic Health Recent Development
13.7 Thermo Fisher Scientific
13.7.1 Thermo Fisher Scientific Company Details
13.7.2 Thermo Fisher Scientific Business Overview
13.7.3 Thermo Fisher Scientific Breast Cancer Liquid Biopsy Introduction
13.7.4 Thermo Fisher Scientific Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
13.7.5 Thermo Fisher Scientific Recent Development
13.8 Illumina
13.8.1 Illumina Company Details
13.8.2 Illumina Business Overview
13.8.3 Illumina Breast Cancer Liquid Biopsy Introduction
13.8.4 Illumina Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
13.8.5 Illumina Recent Development
13.9 Biocept
13.9.1 Biocept Company Details
13.9.2 Biocept Business Overview
13.9.3 Biocept Breast Cancer Liquid Biopsy Introduction
13.9.4 Biocept Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
13.9.5 Biocept Recent Development
13.10 Trovagene
13.10.1 Trovagene Company Details
13.10.2 Trovagene Business Overview
13.10.3 Trovagene Breast Cancer Liquid Biopsy Introduction
13.10.4 Trovagene Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
13.10.5 Trovagene Recent Development
13.11 Guardant Health
10.11.1 Guardant Health Company Details
10.11.2 Guardant Health Business Overview
10.11.3 Guardant Health Breast Cancer Liquid Biopsy Introduction
10.11.4 Guardant Health Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
10.11.5 Guardant Health Recent Development
13.12 RainDance Technologies
10.12.1 RainDance Technologies Company Details
10.12.2 RainDance Technologies Business Overview
10.12.3 RainDance Technologies Breast Cancer Liquid Biopsy Introduction
10.12.4 RainDance Technologies Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
10.12.5 RainDance Technologies Recent Development
13.13 MDx Health
10.13.1 MDx Health Company Details
10.13.2 MDx Health Business Overview
10.13.3 MDx Health Breast Cancer Liquid Biopsy Introduction
10.13.4 MDx Health Revenue in Breast Cancer Liquid Biopsy Business (2015-2020)
10.13.5 MDx Health Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Breast Cancer Liquid Biopsy Key Market Segments
Table 2. Key Players Covered: Ranking by Breast Cancer Liquid Biopsy Revenue
Table 3. Ranking of Global Top Breast Cancer Liquid Biopsy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Breast Cancer Liquid Biopsy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Circulating Tumor Cells (CTCs)
Table 6. Key Players of Cell-Free DNA (CfDNA)
Table 7. Key Players of Extracellular Vesicles (EVs)
Table 8. Key Players of Other Circulating Biomarkers
Table 9. Global Breast Cancer Liquid Biopsy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Breast Cancer Liquid Biopsy Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Breast Cancer Liquid Biopsy Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Breast Cancer Liquid Biopsy Market Share by Regions (2015-2020)
Table 13. Global Breast Cancer Liquid Biopsy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Breast Cancer Liquid Biopsy Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Breast Cancer Liquid Biopsy Market Growth Strategy
Table 19. Main Points Interviewed from Key Breast Cancer Liquid Biopsy Players
Table 20. Global Breast Cancer Liquid Biopsy Revenue by Players (2015-2020) (Million US$)
Table 21. Global Breast Cancer Liquid Biopsy Market Share by Players (2015-2020)
Table 22. Global Top Breast Cancer Liquid Biopsy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breast Cancer Liquid Biopsy as of 2019)
Table 23. Global Breast Cancer Liquid Biopsy by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Breast Cancer Liquid Biopsy Product Solution and Service
Table 26. Date of Enter into Breast Cancer Liquid Biopsy Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Breast Cancer Liquid Biopsy Market Size by Type (2015-2020) (Million US$)
Table 29. Global Breast Cancer Liquid Biopsy Market Size Share by Type (2015-2020)
Table 30. Global Breast Cancer Liquid Biopsy Revenue Market Share by Type (2021-2026)
Table 31. Global Breast Cancer Liquid Biopsy Market Size Share by Application (2015-2020)
Table 32. Global Breast Cancer Liquid Biopsy Market Size by Application (2015-2020) (Million US$)
Table 33. Global Breast Cancer Liquid Biopsy Market Size Share by Application (2021-2026)
Table 34. North America Key Players Breast Cancer Liquid Biopsy Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Breast Cancer Liquid Biopsy Market Share (2019-2020)
Table 36. North America Breast Cancer Liquid Biopsy Market Size by Type (2015-2020) (Million US$)
Table 37. North America Breast Cancer Liquid Biopsy Market Share by Type (2015-2020)
Table 38. North America Breast Cancer Liquid Biopsy Market Size by Application (2015-2020) (Million US$)
Table 39. North America Breast Cancer Liquid Biopsy Market Share by Application (2015-2020)
Table 40. Europe Key Players Breast Cancer Liquid Biopsy Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Breast Cancer Liquid Biopsy Market Share (2019-2020)
Table 42. Europe Breast Cancer Liquid Biopsy Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Breast Cancer Liquid Biopsy Market Share by Type (2015-2020)
Table 44. Europe Breast Cancer Liquid Biopsy Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Breast Cancer Liquid Biopsy Market Share by Application (2015-2020)
Table 46. China Key Players Breast Cancer Liquid Biopsy Revenue (2019-2020) (Million US$)
Table 47. China Key Players Breast Cancer Liquid Biopsy Market Share (2019-2020)
Table 48. China Breast Cancer Liquid Biopsy Market Size by Type (2015-2020) (Million US$)
Table 49. China Breast Cancer Liquid Biopsy Market Share by Type (2015-2020)
Table 50. China Breast Cancer Liquid Biopsy Market Size by Application (2015-2020) (Million US$)
Table 51. China Breast Cancer Liquid Biopsy Market Share by Application (2015-2020)
Table 52. Japan Key Players Breast Cancer Liquid Biopsy Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Breast Cancer Liquid Biopsy Market Share (2019-2020)
Table 54. Japan Breast Cancer Liquid Biopsy Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Breast Cancer Liquid Biopsy Market Share by Type (2015-2020)
Table 56. Japan Breast Cancer Liquid Biopsy Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Breast Cancer Liquid Biopsy Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Breast Cancer Liquid Biopsy Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Breast Cancer Liquid Biopsy Market Share (2019-2020)
Table 60. Southeast Asia Breast Cancer Liquid Biopsy Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Breast Cancer Liquid Biopsy Market Share by Type (2015-2020)
Table 62. Southeast Asia Breast Cancer Liquid Biopsy Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Breast Cancer Liquid Biopsy Market Share by Application (2015-2020)
Table 64. India Key Players Breast Cancer Liquid Biopsy Revenue (2019-2020) (Million US$)
Table 65. India Key Players Breast Cancer Liquid Biopsy Market Share (2019-2020)
Table 66. India Breast Cancer Liquid Biopsy Market Size by Type (2015-2020) (Million US$)
Table 67. India Breast Cancer Liquid Biopsy Market Share by Type (2015-2020)
Table 68. India Breast Cancer Liquid Biopsy Market Size by Application (2015-2020) (Million US$)
Table 69. India Breast Cancer Liquid Biopsy Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Breast Cancer Liquid Biopsy Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Breast Cancer Liquid Biopsy Market Share (2019-2020)
Table 72. Central & South America Breast Cancer Liquid Biopsy Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Breast Cancer Liquid Biopsy Market Share by Type (2015-2020)
Table 74. Central & South America Breast Cancer Liquid Biopsy Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Breast Cancer Liquid Biopsy Market Share by Application (2015-2020)
Table 76. QIAGEN Company Details
Table 77. QIAGEN Business Overview
Table 78. QIAGEN Product
Table 79. QIAGEN Revenue in Breast Cancer Liquid Biopsy Business (2015-2020) (Million US$)
Table 80. QIAGEN Recent Development
Table 81. Roche Diagnostics Company Details
Table 82. Roche Diagnostics Business Overview
Table 83. Roche Diagnostics Product
Table 84. Roche Diagnostics Revenue in Breast Cancer Liquid Biopsy Business (2015-2020) (Million US$)
Table 85. Roche Diagnostics Recent Development
Table 86. Bio-Rad Laboratories Company Details
Table 87. Bio-Rad Laboratories Business Overview
Table 88. Bio-Rad Laboratories Product
Table 89. Bio-Rad Laboratories Revenue in Breast Cancer Liquid Biopsy Business (2015-2020) (Million US$)
Table 90. Bio-Rad Laboratories Recent Development
Table 91. Myriad Genetics Company Details
Table 92. Myriad Genetics Business Overview
Table 93. Myriad Genetics Product
Table 94. Myriad Genetics Revenue in Breast Cancer Liquid Biopsy Business (2015-2020) (Million US$)
Table 95. Myriad Genetics Recent Development
Table 96. Menarini Silicon Biosystems Company Details
Table 97. Menarini Silicon Biosystems Business Overview
Table 98. Menarini Silicon Biosystems Product
Table 99. Menarini Silicon Biosystems Revenue in Breast Cancer Liquid Biopsy Business (2015-2020) (Million US$)
Table 100. Menarini Silicon Biosystems Recent Development
Table 101. Genomic Health Company Details
Table 102. Genomic Health Business Overview
Table 103. Genomic Health Product
Table 104. Genomic Health Revenue in Breast Cancer Liquid Biopsy Business (2015-2020) (Million US$)
Table 105. Genomic Health Recent Development
Table 106. Thermo Fisher Scientific Company Details
Table 107. Thermo Fisher Scientific Business Overview
Table 108. Thermo Fisher Scientific Product
Table 109. Thermo Fisher Scientific Revenue in Breast Cancer Liquid Biopsy Business (2015-2020) (Million US$)
Table 110. Thermo Fisher Scientific Recent Development
Table 111. Illumina Business Overview
Table 112. Illumina Product
Table 113. Illumina Company Details
Table 114. Illumina Revenue in Breast Cancer Liquid Biopsy Business (2015-2020) (Million US$)
Table 115. Illumina Recent Development
Table 116. Biocept Company Details
Table 117. Biocept Business Overview
Table 118. Biocept Product
Table 119. Biocept Revenue in Breast Cancer Liquid Biopsy Business (2015-2020) (Million US$)
Table 120. Biocept Recent Development
Table 121. Trovagene Company Details
Table 122. Trovagene Business Overview
Table 123. Trovagene Product
Table 124. Trovagene Revenue in Breast Cancer Liquid Biopsy Business (2015-2020) (Million US$)
Table 125. Trovagene Recent Development
Table 126. Guardant Health Company Details
Table 127. Guardant Health Business Overview
Table 128. Guardant Health Product
Table 129. Guardant Health Revenue in Breast Cancer Liquid Biopsy Business (2015-2020) (Million US$)
Table 130. Guardant Health Recent Development
Table 131. RainDance Technologies Company Details
Table 132. RainDance Technologies Business Overview
Table 133. RainDance Technologies Product
Table 134. RainDance Technologies Revenue in Breast Cancer Liquid Biopsy Business (2015-2020) (Million US$)
Table 135. RainDance Technologies Recent Development
Table 136. MDx Health Company Details
Table 137. MDx Health Business Overview
Table 138. MDx Health Product
Table 139. MDx Health Revenue in Breast Cancer Liquid Biopsy Business (2015-2020) (Million US$)
Table 140. MDx Health Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Breast Cancer Liquid Biopsy Market Share by Type: 2020 VS 2026
Figure 2. Circulating Tumor Cells (CTCs) Features
Figure 3. Cell-Free DNA (CfDNA) Features
Figure 4. Extracellular Vesicles (EVs) Features
Figure 5. Other Circulating Biomarkers Features
Figure 6. Global Breast Cancer Liquid Biopsy Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Diagnostic Centers Case Studies
Figure 9. Laboratories Case Studies
Figure 10. Breast Cancer Liquid Biopsy Report Years Considered
Figure 11. Global Breast Cancer Liquid Biopsy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Breast Cancer Liquid Biopsy Market Share by Regions: 2020 VS 2026
Figure 13. Global Breast Cancer Liquid Biopsy Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Breast Cancer Liquid Biopsy Market Share by Players in 2019
Figure 16. Global Top Breast Cancer Liquid Biopsy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breast Cancer Liquid Biopsy as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Breast Cancer Liquid Biopsy Revenue in 2019
Figure 18. North America Breast Cancer Liquid Biopsy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Breast Cancer Liquid Biopsy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Breast Cancer Liquid Biopsy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Breast Cancer Liquid Biopsy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Breast Cancer Liquid Biopsy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Breast Cancer Liquid Biopsy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Breast Cancer Liquid Biopsy Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
リキッドバイオプシー用循環バイオマーカーの世界市場（～2026年） Market Analysis and Insights: Global Circulating Biomarker for Liquid Biopsy Market The global Circulating Biomarker for Liquid Biopsy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Circulating Biomarker for Liquid Bi…- 肺がんリキッドバイオプシーの世界市場（～2026年） Lung cancer liquid biopsy helps to detect the epidermal growth factor receptor (EGFR) mutation and other identified mutations, which are responsible for lung cancer. CtDNA and CTCs have been the most explored technologies for commercial applications up to the present time. Market Analysis and Insigh…
- 循環腫瘍細胞（CTC）予後技術の世界市場（～2026年） Circulating tumor cells (CTCs) are specialized rare cells, which have been shed from a primary solid tumor of the body and circulate in the vasculature system of the body, eventually causing metastasis. CTCs act as the seeds for successive development of additional metastatic tumors in distant organ…
- 循環腫瘍細胞（CTC）＆がん幹細胞の世界市場（～2026年） The tumor cells which have shed into lymphatic system and circulated over the body through blood circulation are called as circulating tumor cells. Circulating tumor cells may comprise seeds for metastasis. Stem cells are the type of cells that can differentiate into specialized cells and have the c…
- 定位乳房生検の世界市場（～2026年） Abnormalities in the breast or lumps are often noticed by mammography, physical examination, or other imaging studies. North America is leading the global Stereotactic Breast Biopsy Market due to increased awareness better reimbursement policies and advances technology. Market Analysis and Insights…